Market By Component, Filling Material, Industry Verticals And Region | Forecast 2019-2028
According to an analysis by Triton Market Research, the intragastric balloon market in North America is likely to augment at a CAGR of 12.48% over the forthcoming period between 2019 and 2028.
Report scope can be customized per your requirements. Request For Customization
The countries evaluated in the North American intragastric balloon market are:
• Canada
• The United States
In the United States, the prevalence of obesity has grown to about 35%. In 2013, the AMA (American Medical Association) declared obesity a disease. This removed a major barrier to medical access for patients with obesity. Obesity is often translated into major inequities in various sectors like education, employment and healthcare, owing to the negative stereotypes. The CMS (Centers for Medicare & Medicaid Services) expanded their coverage to include several other types of devices and procedures, initially in 2006, and later in 2012. This agency even pays for about 20% of the bariatric procedures performed in the country. The alarming increase in the prevalence of obesity, along with the low tolerability of weight loss drugs, has offered an immense opportunity for intragastric balloon manufacturers to penetrate the market. This is helping the market growth in the US.
In Canada, the government promotes healthy eating and physical activity for maintaining a healthy weight. In 2015, the ministers of sport, physical activity and recreation declared the second e-report on the progress of healthy weights in the country. Curbing Childhood Obesity is a government-endorsed FPT Framework, launched in 2010, for implementing actions to encourage healthy weights. These developments indicate an increased potential for the application of intragastric balloon implementation, thereby aiding the market growth.
Established in 2009, Allurion Technologies Inc is a company involved in the manufacturing of medical devices used for the treatment of obesity. Elipse, the flagship device of the company, is the first swallowable gastric balloon. It requires no anesthesia surgery or endoscopy. Although this device has not been approved for sale in the US, it is available in different countries, including France, the UK and Italy. It is headquartered in Massachusetts, the US.
1. NORTH AMERICA INTRAGASTRIC BALLOON MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1.MARKET DEFINITION
2.2.EVOLUTION AND TRANSITION OF INTRAGASTRIC BALLOONS
2.3.PORTER’S FIVE FORCES MODEL
2.3.1.THREAT OF NEW ENTRANTS
2.3.2.THREAT OF SUBSTITUTE PRODUCTS
2.3.3.BARGAINING POWER OF BUYERS
2.3.4.BARGAINING POWER OF SUPPLIERS
2.3.5.COMPETITIVE RIVALRY
2.4.COVID-19 AND ITS IMPACT ON INTRAGASTRIC BALLOON MARKET
2.5.INDUSTRY COMPONENTS
2.6.SUPPLY CHAIN OUTLOOK
2.7.MARKET ATTRACTIVENESS INDEX
2.8.VENDOR SCORECARD
2.9.KEY INSIGHT
2.10.MARKET DRIVERS
2.10.1.SHORT DURATION OF HOSPITAL STAY AND RECOVERY TIME
2.10.2.RISING OBESITY
2.11.MARKET RESTRAINTS
2.11.1.SHORT-TERM EFFECTS ASSOCIATED WITH INTRAGASTRIC BALLOONING
2.11.2.REIMBURSEMENT ISSUE
2.12.MARKET OPPORTUNITIES
2.12.1.RISE IN THE GOVERNMENT INITIATIVES REGARDING OBESITY
2.12.2.CONCERNS ASSOCIATED WITH MORBID LIFESTYLE
2.13.MARKET CHALLENGES
2.13.1.STRINGENT PRODUCT APPROVAL PROCEDURE
3. INTRAGASTRIC BALLOON MARKET OUTLOOK - BY COMPONENT
3.1.SINGLE BALLOON
3.2.DUAL BALLOON
3.3.TRIPLE BALLOON
4. INTRAGASTRIC BALLOON MARKET OUTLOOK - BY FILLING MATERIAL
4.1.SALINE-FILLED
4.2.GAS-FILLED
5. INTRAGASTRIC BALLOON MARKET OUTLOOK - BY INDUSTRY VERTICALS
5.1.CLINICS
5.2.HOSPITALS
5.3.AMBULATORY SURGICAL CENTERS
6. INTRAGASTRIC BALLOON MARKET OUTLOOK – BY NORTH AMERICA
6.1.THE UNITED STATES
6.2.CANADA
7. COMPANY PROFILE
7.1.ALLURION TECHNOLOGIES INC
7.2.MEDSIL
7.3.ALLERGAN (ABBVIE)
7.4.OBALON THERAPEUTICS
7.5.APOLLO ENDOSURGERY INC
7.6.RESHAPE LIFESCIENCES INC
7.7.ASPIRE BARIATRICS
7.8.BARONOVA
7.9.DISTRICLASS MEDICAL
7.10.ENDALIS
7.11.MEDTRONIC
7.12.SILIMED (SIENTRA INC)
7.13.HELIOSCOPIE
7.14.SPATZ FGIA INC
8. RESEARCH METHODOLOGY & SCOPE
8.1.RESEARCH SCOPE & DELIVERABLES
8.1.1.OBJECTIVES OF STUDY
8.1.2.SCOPE OF STUDY
8.2.SOURCES OF DATA
8.2.1.PRIMARY DATA SOURCES
8.2.2.SECONDARY DATA SOURCES
8.3.RESEARCH METHODOLOGY
8.3.1.EVALUATION OF PROPOSED MARKET
8.3.2.IDENTIFICATION OF DATA SOURCES
8.3.3.ASSESSMENT OF MARKET DETERMINANTS
8.3.4.DATA COLLECTION
8.3.5.DATA VALIDATION & ANALYSIS
TABLE 1 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY COMPONENT, 2019-2028 ($ MILLION)
TABLE 4 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY FILLING MATERIAL, 2019-2028 ($ MILLION)
TABLE 5 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY INDUSTRY VERTICALS, 2019-2028 ($ MILLION)
TABLE 6 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
FIGURE 1 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, 2019-2028 ($ MILLION)
FIGURE 2 INDUSTRY COMPONENTS OF INTRAGASTRIC BALLOON PRODUCTS
FIGURE 3 SUPPLY CHAIN OUTLOOK OF INTRAGASTRIC BALLOON
FIGURE 4 CAUSES OF OBESITY AND OVERWEIGHT
FIGURE 5 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY COMPONENT, 2019-2028 ($ MILLION)
FIGURE 6 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY SINGLE BALLOON, 2019-2028 ($ MILLION)
FIGURE 7 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY DUAL BALLOON, 2019-2028 ($ MILLION)
FIGURE 8 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY TRIPLE BALLOON, 2019-2028 ($ MILLION)
FIGURE 9 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY FILLING MATERIAL, 2019-2028 ($ MILLION)
FIGURE 10 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY SALINE-FILLED, 2019-2028 ($ MILLION)
FIGURE 11 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY GAS-FILLED, 2019-2028 ($ MILLION)
FIGURE 12 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY INDUSTRY VERTICALS, 2019-2028 ($ MILLION)
FIGURE 13 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY CLINICS, 2019-2028 ($ MILLION)
FIGURE 14 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY HOSPITALS, 2019-2028 ($ MILLION)
FIGURE 15 NORTH AMERICA INTRAGASTRIC BALLOON MARKET, BY AMBULATORY SURGICAL CENTERS, 2019-2028 ($ MILLION)
FIGURE 16 UNITED STATES INTRAGASTRIC BALLOON MARKET, 2019-2028 ($ MILLION)
FIGURE 17 CANADA INTRAGASTRIC BALLOON MARKET, 2019-2028 ($ MILLION)